Review Article
Candida Chorioamnionitis Leads to Preterm Birth and Adverse Fetal-Neonatal Outcome
Table 5
Antenatal treatment for Candida chorioamnionitis.
| GA at diagnosis (weeks) | GA at delivery (weeks) | Species | Antifungal agent | Administration route | Fetal/neonatal outcomes | Reference |
| 19 | 19 | Candida albicans | Fluconazole | Intravenous | Stillbirth | [74] | 19 | 21 | C. albicans | Fluconazole | Oral | Stillbirth | [75] | 21 | 22 | C. albicans | Fluconazole | Oral | Stillbirth | [64] | 21 | 27 | C. albicans | Fluconazole | Transabdominal intra-amniotic, oral, and vaginal | Alive | [71] | 23 | 31 | C. albicans | Fluconazole | Transabdominal intra-amniotic, oral, and vaginal | Alive | [71] | 26 | 29 | C. glabrata | Fluconazole | Intravenous | Alive (PVL)/alive | [81] | 18 | 23 | C. glabrata | Amphotericin B | Intravenous | Stillbirth | [88] | 21 | 24 | C. glabrata | Amphotericin B | Intravenous | Stillbirth/stillbirth | [87] | 24 | 24 | C. glabrata | Amphotericin B | Intravenous | Died on day 42 | [76] | 24 | 28 | C. glabrata | Amphotericin B | Intravenous | Alive/alive | [89] | 27 | 29 | C. albicans | Amphotericin B | Transcervical intra-amniotic | Alive | [44] | 21 | 21 | C. albicans | Ketoconazole | Not described | Stillbirth | [91] | 26 | 28 | C. glabrata | Micafungin | Intravenous | Alive | [41] |
|
|
GA, gestational age; PVL, periventricular leukomalacia.
|